Skip to main content
ANAB
NASDAQ Life Sciences

AnaptysBio 在 Q4 实现 4960 万美元净收入

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$52.83
Mkt Cap
$1.463B
52W Low
$13.99
52W High
$57.74
Market data snapshot near publication time

summarizeSummary

AnaptysBio 公布了其第四季度财务报告，报告净收入为 4960.614 万美元。该公司还公布了合作收入为 108.249 万美元和经营收入为 66.901 万美元。这些数据为公司最近的财务表现提供了关键的洞察。虽然标题提供了具体的数字，但没有指出这些结果是否达到、超过或低于分析师的共识预期，这对于股票价格的立即反应至关重要。交易者将分析这些原始数据，并等待来自完整财务报告的进一步背景。

在该公告发布时，ANAB的交易价格为$52.83，交易所为NASDAQ，所属行业为Life Sciences，市值约为$14.6亿。 52周交易区间为$13.99至$57.74。 这则新闻被评估为中性市场情绪，重要性评分为7/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed ANAB - Latest Insights

ANAB
Apr 27, 2026, 2:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
AnaptysBio Secures Delaware Court Dismissal in GSK Case
Sentiment: Positive
View Wiseek Article
ANAB
Apr 24, 2026, 4:17 PM EDT
Filing Type: 8-K/A
Importance Score:
8
AnaptysBio Files Pro Forma Financials Post-Spin-Off of First Tracks Biotherapeutics
Sentiment: Neutral
View Wiseek Article
ANAB
Apr 24, 2026, 3:41 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Delaware Court Dismisses Tesaro Breach Claim Against AnaptysBio
Sentiment: Positive
View Wiseek Article
ANAB
Apr 20, 2026, 5:33 PM EDT
Source: Wiseek News
Importance Score:
8
AnaptysBio Completes Spin-Off, Transfers $100M to First Tracks in Separation Deal
Sentiment: Positive
View Wiseek Article
ANAB
Apr 20, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics, Retains $140M+ Cash, and Transitions to Royalty Management Model
Sentiment: Positive
View Wiseek Article
ANAB
Apr 20, 2026, 1:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
AnaptysBio Soars to 52-Week High Post-Spinoff; First Tracks Biotherapeutics Shares Decline
Sentiment: Positive
View Wiseek Article
ANAB
Mar 27, 2026, 9:19 AM EDT
Filing Type: 8-K
Importance Score:
9
AnaptysBio Approves Spin-Off of First Tracks Biotherapeutics, Authorizes $100M Buyback, and Appoints Key Director
Sentiment: Positive
View Wiseek Article
ANAB
Mar 27, 2026, 9:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
$145M Private Placement Secured for AnaptysBio's Spin-Off, First Tracks Biotherapeutics
Sentiment: Positive
View Wiseek Article
ANAB
Mar 03, 2026, 4:15 PM EST
Source: Reuters
Importance Score:
7
AnaptysBio Posts $49.6 Million Net Income in Q4
Sentiment: Neutral
View Wiseek Article
ANAB
Mar 03, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
9
AnaptysBio to Spin Off Biopharma Unit as First Tracks Biotherapeutics in Q2 2026 to Unlock Value
Sentiment: Positive
View Wiseek Article